311 related articles for article (PubMed ID: 27382941)
1. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
[TBL] [Abstract][Full Text] [Related]
2. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ
Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of IgG4-positive plasma cell infiltrates in inflammatory bowel disease patients without autoimmune pancreatitis.
Topal F; Sarıtaş Yüksel E; Ekinci N; Pekdiker M; Cakalağaoğlu F; Alper E; Unsal B
Turk J Gastroenterol; 2014 Oct; 25(5):558-62. PubMed ID: 25417619
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
5. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
[TBL] [Abstract][Full Text] [Related]
6. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
7. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
8. Beta-defensin production by human colonic plasma cells: a new look at plasma cells in ulcerative colitis.
Rahman A; Fahlgren A; Sitohy B; Baranov V; Zirakzadeh A; Hammarström S; Danielsson A; Hammarström ML
Inflamm Bowel Dis; 2007 Jul; 13(7):847-55. PubMed ID: 17387677
[TBL] [Abstract][Full Text] [Related]
9. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
10. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
12. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
[TBL] [Abstract][Full Text] [Related]
14. Biopsy histamine in ulcerative colitis and Crohn's disease.
Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
17. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
18. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT
Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138
[TBL] [Abstract][Full Text] [Related]
20. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
